Model bioequivalence data summary tables-FDA [RSABE / ABEL]

posted by kumarnaidu – Mumbai, India, 2014-08-20 09:04 (4330 d 09:11 ago) – Posting: # 13410
Views: 11,241

Hello every one,

I have one question regarding filling of Table 3A and 3B of Model bioequivalence data summary tables-FDA.
Table 3A Statistical Summary of the Comparative Bioavailability Data for
Unscaled Average BE Studies.

Table 3B Statistical Summary of the Comparative Bioavailability Data for
Reference-Scaled Average BE Studies.


As per the form if Reference Scaled Average Bioequivalence Approach Used then complete Tables 3A and 3B

In one of our study we used Reference scaled approach for all three parameters (Swr >0.294 for Cmax, AUCt and AUCinf). Then here should we also need to analyse these parameters using unscaled approach?

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
370 visitors (0 registered, 370 guests [including 14 identified bots]).
Forum time: 18:16 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5